Navigation Links
Akers Biosciences, Inc. 'ABI' or the 'Company' Receipt of Further United States Military Contracts
Date:9/17/2007

THOROFARE, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Akers Biosciences, Inc. (LSE: AKR) which develops, manufactures, and supplies rapid, point of care screening and testing products, is pleased to announce that it has received an order from the United States Army for the purchase of its BreathScan alcohol safety units. This contract is valued at $2,500,000 and is deliverable beginning immediately.

The Company has previously stated that it had expected significant orders from several departments of the United States Government as a result of its' efforts to increase safety awareness. ABI continues to anticipate such further orders in the near future. The units provided consist of the Company's unique, patented disposable breathalyzer device housed within its patented, portable and refillable key ring case.

Thomas A. Nicolette, President and CFO of ABI, commented, "This latest order will take the total number of our BreathScan alcohol safety units in use by the US Military to over 950,000. This is the beginning of a recurring revenue business model generated from this product line, where the alcohol breathalyzers will continually require replacement as they are used and disposed of. We confidently expect other divisions of the United States Military to introduce our product line over the course of the very near future.

This is the clearest progressive step to date in transforming ABI from a purely research and development company to business that is capitalizing on its proprietary product lines and generating sustainable revenues from them."

Akers Biosciences

Akers Biosciences, Inc. develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the patient or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. Akers has aligned with major healthcare companies and high volume medical products distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics. Additional information on the Company and its products can be found at http://www.akersbiosciences.com.

Contact:

Akers Biosciences, Inc.

Thomas A. Nicolette, President & CFO

Tel (856) 848-8698


'/>"/>
SOURCE Akers Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers identify the early makers of Neonatal Sepsis
2. Epilepsy Patients Could Benefit From Pacemakers
3. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
4. Stem Cells Could Replace Electronic Pacemakers
5. Lawmakers alerted on new tobacco control policies by research team
6. Chocolate makers to be health wise and urge consumers to be too!
7. Drug Makers Banned From Providing Gifts To Doctors
8. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
9. Lawsuit Against Sunscreen Makers For False Claims of Protection Against Skin Cancer
10. Sensing The Health Hazard MP3 Makers Tone Down The Volume
11. Reliability of Pacemakers and Defibrillators to be Improved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... ... first-quality education and high-level training standards to an international multidisciplinary group of healthcare ... problems. As a way to further its mission at the grassroots level, iaedp ...
(Date:1/15/2017)... NY (PRWEB) , ... January 15, 2017 , ... In ... accounts in the United States for the asthma & allergy friendly mark. This certification ... to independently test and identify consumer products to be more suitable for the 60+ ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco Magazine recently ... Area counties for 2017. Almost 1,000 nominations were submitted and a little over ... Results were announced the magazine’s January 2017 issue . , Under the ...
(Date:1/14/2017)... ... 2017 , ... According to a December 9 article ... the risk of type 2 diabetes, Alzheimer’s, and cardiovascular disease. Southern California based ... linked to a Mediterranean diet are only some of the many reasons that ...
(Date:1/13/2017)... ... , ... A January 10 article in the Daily Star on ... with an emphasis on some new techniques that the publication says are becoming more ... casually to his patients and colleagues as Dr. J, comments that the best plastic ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... , Jan. 13, 2017  Alfalfa, cattle, leafy greens and ... environmental sampling film , which emphasizes the food industry,s shift ... highlights how COPAN,s Swab Rinse Kit ... the surface sampling process in the wake of the new ... COPAN is expanding the U.S. production ...
(Date:1/13/2017)... 2017 The 2016 election resulted in ... states voting in favor of legalizing cannabis for recreational use, ... in the U.S. In addition, the state of ... cannabis products sales. The ArcView Group has published an updated ... cannabis sales in the U.S. last year reached $6.7 billion, a ...
(Date:1/13/2017)... 2017 Research and Markets has announced the ... report to their offering. ... Cystic fibrosis (CF) is a progressive genetic condition ... fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective ... and result in the buildup of a thick and sticky mucus ...
Breaking Medicine Technology: